COCRYSTAL PHARMA, INC. Accrued Liabilities, Current
COCRYSTAL PHARMA, INC. (COCP) had Accrued Liabilities, Current of $1.09 million as of 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2017-08-08
- 2017-06-30: Accrued Liabilities, Current $1.09M.
- 2017-03-31: Accrued Liabilities, Current $1.12M.
- 2016-12-31: Accrued Liabilities, Current $563.00K.
- 2015-12-31: Accrued Liabilities, Current $2.58M; Accrued Liabilities, Current as first filed $2.54M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2017-06-30 | $1.09M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.12M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $563.00K 10-Q · filed 2017-08-08 | |
| 2015-12-31 | $2.58M 10-K · filed 2017-03-31 | $2.54M 10-K · filed 2016-03-15 |
| 2015-09-30 | $331.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $381.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $455.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $693.00K 10-K · filed 2016-03-15 | $394.00K 10-K · filed 2015-03-31 |
| 2014-09-30 | $290.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $281.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $177.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $139.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |